Guidelines for nebulized sinus treatments. (Product Marketplace).

Dr. Keith Wahl, chief of Otolaryngology at Scripps Memorial Hospital, recently published treatment guidelines for SinuNEB[TM] prescription medications based on data from the Scheinberg study (Ear Nose Throat J 2002;81:648-52) and the Stanford study (Otolaryngol Head Neck Surg 2002;127:558-68).

Dr. Wahl recommends prescribing antibiotics to be nebulized intranasally using the SinuNEB System because of the performance of SinusPharmacy's AdhesENT[TM]-based formulations, specialized nasal nebulizer and personalized patient services. He concludes that the use of prescribed antibiotics with the SinuNEB System has been safe and effective, with the following findings: "(1 )Specially formulated medication compounds delivered through intranasal nebulization are well tolerated. (2) A 300% increase in infection-free periods [after patients used] AdhesENT-formulated intranasal medication treatment, compared to prior systemic therapy [oral or IV therapy]. (3) An 82.9% good or excellent patient response to AdhesENT-formulated intranasal nebulized q medications [was documented in a 2-year private practice review)."

For reprints of the published data or for additional information, please call SinusPharmacy toll-free at [phone].